卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAH 卡地纳健康

交易中 06-10 11:20:56 EDT

218.64

+5.97

+2.81%

最高218.86	最低211.50	成交量93.88万
今开213.79	昨收212.67	日振幅3.46%
总市值514.49亿	流通市值514.49亿	总股本2.35亿
成交额2.04亿	换手率0.40%	流通股本2.35亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAH","market":"US","secType":"STK","nameCN":"卡地纳健康","latestPrice":218.64,"timestamp":1781104855546,"preClose":212.67,"halted":0,"volume":938780,"delay":0,"changeRate":0.028071660318803777,"floatShares":235316016,"shares":235316016,"eps":6.53725,"marketStatus":"交易中","change":5.97,"latestTime":"06-10 11:20:56 EDT","open":213.785,"high":218.86,"low":211.495,"amount":204010731.6172,"amplitude":0.034631,"askPrice":218.42,"askSize":1,"bidPrice":218.37,"bidSize":1,"shortable":3,"etf":0,"ttmEps":6.53725,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781121600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":428558400000,"exchange":"NYSE","adjPreClose":212.67,"dividendRate":0.009338,"preHourTrading":{"tag":"盘前","latestPrice":211.23,"preClose":212.67,"latestTime":"09:29 EDT","volume":1878,"amount":399565.98432,"timestamp":1781098186979,"change":-1.44,"changeRate":-0.006771,"amplitude":0.030673},"postHourTrading":{"tag":"盘后","latestPrice":212.67,"preClose":212.67,"latestTime":"19:58 EDT","volume":160298,"amount":34090065.8358,"timestamp":1781049532133,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.671388,"impliedVol":0.2827,"impliedVolPercentile":0.4223},"requestUrl":"/m/hq/s/CAH/wiki","defaultTab":"wiki","newsList":[{"id":"1131849406","title":"异动解读 | 成本压力与增长放缓，卡地纳健康盘中大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131849406","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131849406?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:39","pubTimestamp":1777556343,"startTime":"0","endTime":"0","summary":"卡地纳健康（CAH）今日盘中股价大跌5.33%，市场表现引人关注。消息面上，公司高管在电话会议中透露，与《通胀削减法案》相关的批发采购成本调整对公司整体增长率产生了下行压力。同时，尽管GLP-1类药物销量增长率仍保持在30%以上，但增长势头已较此前明显放缓。这些因素共同影响了市场对该公司短期增长前景的预期，可能是导致股价承压下跌的主要原因。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143971235","title":"卡地纳健康高管称《通胀削减法案》相关批发采购成本变动拖累整体增长率 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1143971235","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143971235?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:24","pubTimestamp":1777555477,"startTime":"0","endTime":"0","summary":"卡地纳健康高管在电话会议中透露，与《通胀削减法案》相关的批发采购成本调整对公司整体增长率产生了下行压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930227.SGD","LU0310799852.SGD","BK4588","LU0162691827.USD","LU1880398471.USD","LU0310800965.SGD","LU0006061336.USD","LU0072461881.USD","LU0154236417.USD","LU1880398554.USD","LU0052756011.USD","LU1571399168.USD","LU1267930813.SGD","SG9999001440.SGD","BK4175","LU0211327993.USD","BK4585","LU1267930490.SGD","LU0211328371.USD","LU0889566641.SGD","LU1983299246.USD","LU0128525689.USD","CAH","LU0792757196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135092418","title":"卡地纳健康高管：GLP-1药物销量增速仍超30%，但较此前有所放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=1135092418","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135092418?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:21","pubTimestamp":1777555302,"startTime":"0","endTime":"0","summary":"卡地纳健康公司高管在电话会议中透露，尽管GLP-1类药物销量增长率仍保持在30%以上，但增长势头已较此前明显放缓。\n该公司指出，这类用于糖尿病和肥胖症治疗的药物持续保持强劲需求，但市场扩张速度正在逐步回归理性区间。目前GLP-1药物业务仍是卡地纳健康重要的增长驱动力之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930227.SGD","LU0310799852.SGD","BK4588","LU0162691827.USD","LU1880398471.USD","LU0310800965.SGD","LU0006061336.USD","LU0072461881.USD","LU0154236417.USD","LU1880398554.USD","LU0052756011.USD","LU1571399168.USD","LU1267930813.SGD","SG9999001440.SGD","BK4175","LU0211327993.USD","BK4585","LU1267930490.SGD","LU0211328371.USD","LU0889566641.SGD","LU1983299246.USD","LU0128525689.USD","CAH","LU0792757196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136207744","title":"卡地纳健康扩大锕-225产能，以满足新型癌症疗法日益增长的需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1136207744","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136207744?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:01","pubTimestamp":1775041305,"startTime":"0","endTime":"0","summary":"为应对市场对创新癌症治疗手段不断攀升的需求，卡地纳健康已宣布扩大其放射性同位素锕-225的生产规模。此次产能提升旨在保障这种关键治疗材料的稳定供应，从而支持靶向放射性药物等前沿疗法的研发与应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1267930227.SGD","CAH","LU0006061336.USD","LU0310799852.SGD","LU1880398471.USD","LU0154236417.USD","BK4175","LU1571399168.USD","LU0162691827.USD","LU1267930813.SGD","LU0211327993.USD","LU0128525689.USD","LU0211328371.USD","LU1880398554.USD","LU0310800965.SGD","LU1267930490.SGD","SG9999001440.SGD","LU0889566641.SGD","LU0792757196.USD","BK4588","LU0072461881.USD","LU0052756011.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115618181","title":"异动解读 | 卡地纳健康盘中大涨5.35%，因上调利润预期且季度业绩超华尔街预估","url":"https://stock-news.laohu8.com/highlight/detail?id=1115618181","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115618181?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:41","pubTimestamp":1770302460,"startTime":"0","endTime":"0","summary":"卡地纳健康今日盘中大涨5.35%，引起了市场的广泛关注。消息面上，公司上调了2026财年调整后利润预期，从此前的每股至少10美元上调至10.15美元至10.35美元之间。同时，公司公布的季度营收为656.3亿美元，高于分析师平均预期的641.4亿美元；调整后每股利润为2.63美元，也高于预期的2.36美元。业绩超预期主要得益于特药需求的强劲增长。在截至去年12月31日的季度，公司的制药和特药解决方案部门收入同比增长19%，达到607亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609239269","title":"卡地纳健康盘中异动 快速下挫5.05%报206.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609239269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609239269?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:47","pubTimestamp":1770216424,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时47分，卡地纳健康股票出现波动，股价急速跳水5.05%。截至发稿，该股报206.99美元/股，成交量22.9129万股，换手率0.10%，振幅4.88%。最近的财报数据显示，该股实现营业收入640.09亿美元，净利润4.50亿美元，每股收益1.89美元，毛利22.32亿美元，市盈率31.37倍。机构评级方面，在所有20家参与评级的机构中，80%的券商给予买入建议，15%的券商给予持有建议，5%的券商给予卖出建议。卡地纳健康股票所在的医疗销售行业中，整体跌幅为3.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204224705a47c5c50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204224705a47c5c50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1267930813.SGD","LU1571399168.USD","LU0310799852.SGD","LU0052756011.USD","LU0889566641.SGD","LU1880398554.USD","LU1267930227.SGD","LU0128525689.USD","BK4175","LU0211327993.USD","LU0006061336.USD","LU0072461881.USD","BK4585","BK4588","SG9999001440.SGD","LU1267930490.SGD","LU0211328371.USD","LU1880398471.USD","LU0310800965.SGD","LU0162691827.USD","LU0154236417.USD","LU0792757196.USD","CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138464786","title":"卡地纳健康预计2026财年生物制药解决方案业务收入将增长逾30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138464786","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138464786?lang=zh_cn&edition=full","pubTime":"2026-01-13 19:51","pubTimestamp":1768305085,"startTime":"0","endTime":"0","summary":"卡地纳健康公司近日发布业绩展望，其生物制药解决方案部门在2026财年有望实现超过30%的营收增长。这一积极预期凸显了该公司在医药分销领域的战略布局正收获显著成效。\n随着全球生物制药市场持续扩张，卡地纳健康通过优化供应链管理和拓展专业服务能力，成功抓住了行业增长机遇。公司管理层表示，这一增长动力主要来源于与生物技术企业合作的深化及特药分销网络的扩展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU1571399168.USD","LU0310799852.SGD","LU0052756011.USD","LU0889566641.SGD","LU1880398554.USD","LU1267930227.SGD","LU0128525689.USD","BK4175","LU0211327993.USD","LU0006061336.USD","LU0072461881.USD","BK4585","BK4588","SG9999001440.SGD","LU1267930490.SGD","LU0211328371.USD","LU1880398471.USD","LU0310800965.SGD","LU0162691827.USD","LU0154236417.USD","LU0792757196.USD","CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104652609","title":"卡地纳健康在摩根大通医疗健康大会上提升2026财年业绩展望并强调战略进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1104652609","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104652609?lang=zh_cn&edition=full","pubTime":"2026-01-13 19:50","pubTimestamp":1768305028,"startTime":"0","endTime":"0","summary":"在近日举行的摩根大通医疗健康大会上，卡地纳健康公司宣布上调其2026财年的业绩预期，同时向与会者详细阐述了公司在战略执行方面取得的显著进展。\n此次展望的提升反映了管理层对公司核心业务增长动能及未来市场机遇的坚定信心。公司高层在演讲中重点介绍了其在供应链优化、医疗服务拓展以及技术创新等关键领域的战略性投入与成果，勾勒出更加清晰和积极的发展路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525689.USD","LU1267930227.SGD","LU0211327993.USD","LU0211328371.USD","LU1880398554.USD","CAH","LU0052756011.USD","LU0310800965.SGD","BK4585","LU0006061336.USD","LU0154236417.USD","SG9999001440.SGD","LU1571399168.USD","LU0792757196.USD","LU1880398471.USD","LU1267930813.SGD","BK4175","LU1267930490.SGD","LU0072461881.USD","LU0162691827.USD","LU0310799852.SGD","BK4588","LU0889566641.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175526367","title":"美股波动预期加剧，这些稳健的高股息股可为投资组合保驾护航","url":"https://stock-news.laohu8.com/highlight/detail?id=1175526367","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175526367?lang=zh_cn&edition=full","pubTime":"2025-02-20 15:12","pubTimestamp":1740035549,"startTime":"0","endTime":"0","summary":"随着2025年美股市场波动预期加剧，投资者或可考虑增持高股息股票以平滑投资风险。在市场波动时期，稳定派息股票常被视为“压舱石”，其股息收入能够在股价下跌时提供缓冲。其中，“股息贵族”尤其值得关注，这些公司已连续至少25年提高股息。此外，这些股票的股息率均高于标准普尔500指数1.24%的水平。该公司本月宣布计划拆分生命科学和诊断业务。今年以来该股股价微跌。年内股价下跌超6%，但目标价隐含18%上涨空间。","market":"us","thumbnail":"https://community-static.tradeup.com/news/daf8c6efec812c4e4d5211ffbcf205b8","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/daf8c6efec812c4e4d5211ffbcf205b8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美股波动预期加剧，这些稳健的高股息股可为投资组合保驾护航","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRT","CAH","PG","NEE","CVX","EMR","BDX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2509410816","title":"Gangtise投研日报 | 2025-02-05","url":"https://stock-news.laohu8.com/highlight/detail?id=2509410816","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509410816?lang=zh_cn&edition=full","pubTime":"2025-02-05 06:30","pubTimestamp":1738708200,"startTime":"0","endTime":"0","summary":"　　1．深圳机场预计2024年归属于上市公司股东的净利润为3.998亿元至4.438亿元，同比增长0.78%至11.88%。扣除非经常性损益后，预计净利润为2.961亿元至3.561亿元，同比增长289.24%至327.59%。基本每股收益预计为0.195元/股至0.2164元/股。经营态势良好，营业收入增幅远大于成本费用增幅。　　5． United Microelectronics Corporation 2024年第四季度业绩电话会：2024年第四季度，联电合并营收为504亿新台币，毛利率30.4%，股东应占净收入85亿新台币，每股收益4.682美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-05/doc-ineiktkp5483790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE0009355771.USD","IE00B2B36J28.USD","BK4175","LU0128525689.USD","LU1571399168.USD","LU0211331839.USD","BK4141","LU1267930490.SGD","LU0162691827.USD","LU1267930813.SGD","LINRF","BK4080","BK4588","BK4554","LU1880398554.USD","LU0072461881.USD","CAH","LU0889566641.SGD","IE0002141913.USD","BK4168","IE00BJJMRZ35.SGD","LU1880398471.USD","LU0310800965.SGD","BK4231","BK4578","LU0211328371.USD","LU0154236417.USD","ROIC","LU0052756011.USD","BK4007","BK4526","LU0310799852.SGD","BK4532","LU1267930227.SGD","BK4585","LU0006061336.USD","NVS","SG9999001440.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0211327993.USD","LU0792757196.USD","IE00BJT1NW94.SGD","UMC","BK4017","NESRF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508468929","title":"小摩：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由142.00美元调整至145.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468929","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508468929?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:13","pubTimestamp":1738681987,"startTime":"0","endTime":"0","summary":"小摩：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由142.00美元调整至145.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04231347949905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507644448","title":"Cardinal Health(CAH.US)：2025年Q2财报实现营收552.64亿美元，前值为574.45亿美元，预期值为549.7亿美元；每股收益为1.93美元，前值为1.89美元，预期值为1.76美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507644448","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507644448?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:54","pubTimestamp":1738238063,"startTime":"0","endTime":"0","summary":"Cardinal Health(CAH.US)：2025年Q2财报实现营收552.64亿美元，前值为574.45亿美元，预期值为549.7亿美元；每股收益为1.93美元，前值为1.89美元，预期值为1.76美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30195447908896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192403175","title":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1192403175","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192403175?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:52","pubTimestamp":1738237978,"startTime":"0","endTime":"0","summary":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期以上内容来自Benzinga Earnings专栏，原文如下：Cardinal Health Q2 2025 Adj. EPS $1.93 Beats $1.76 Estimate, Sales $55.3B Beat $54.915B Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507042684","title":"富国银行：维持Cardinal Health(CAH.US)评级，由持股观望调整至持股观望评级, 目标价由127.00美元调整至135.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507042684","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507042684?lang=zh_cn&edition=full","pubTime":"2025-01-29 19:42","pubTimestamp":1738150962,"startTime":"0","endTime":"0","summary":"富国银行：维持Cardinal Health(CAH.US)评级，由持股观望调整至持股观望评级, 目标价由127.00美元调整至135.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29194247896901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502381667","title":"花旗：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由120.00美元调整至129.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502381667","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502381667?lang=zh_cn&edition=full","pubTime":"2025-01-11 03:11","pubTimestamp":1736536303,"startTime":"0","endTime":"0","summary":"花旗：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由120.00美元调整至129.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/11031147365003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502062017","title":"TD Cowen：上调Cardinal Health(CAH.US)评级，由持有调整至买入评级, 目标价由130.00美元调整至144.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502062017","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502062017?lang=zh_cn&edition=full","pubTime":"2025-01-09 02:03","pubTimestamp":1736359381,"startTime":"0","endTime":"0","summary":"TD Cowen：上调Cardinal Health(CAH.US)评级，由持有调整至买入评级, 目标价由130.00美元调整至144.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/09020347279995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH","TD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501208068","title":"Evercore ISI Group：上调Cardinal Health评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2501208068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501208068?lang=zh_cn&edition=full","pubTime":"2025-01-07 19:36","pubTimestamp":1736249812,"startTime":"0","endTime":"0","summary":"evercore ISI Group：上调Cardinal Health(CAH.US)评级，由大市同步调整至优于大市评级,目标价由140.00美元调整至140.00美元。卡地纳健康(CAH.US)公司简介：卡地纳健康集团是一家医疗保健服务和产品公司，从事为医院、医疗保健系统、药房、门诊手术中心、临床实验室和医生办公室提供定制解决方案。它还提供医疗产品和药品以及具有成本效益的解决方案，以提高供应链效率。该公司通过制药和医疗部门运营。制药部门分销品牌和仿制药，专业药品和非处方医疗保健和消费品。医疗部门生产、采购和分销卡地纳健康品牌的医疗、外科和实验室产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107194539a218c113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107194539a218c113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAH","EVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492942352","title":"【券商聚焦】摩根士丹利：北美医疗保健服务行业MA预期改善 个股目标价及评级各有调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2492942352","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492942352?lang=zh_cn&edition=full","pubTime":"2024-12-18 10:37","pubTimestamp":1734489456,"startTime":"0","endTime":"0","summary":"摩根士丹利对这一领域的评级为“与市场一致”。此外，对于医疗保健技术和提供商，摩根士丹利建议保持选择性，因为需求和政策不确定性混合。对于行业中一些公司，摩根士丹利给出了以下评级和预期：对于Elevance Health Inc，摩根士丹利将其评级从“跑赢大市”下调至“与大市同步”，目标价从551美元降至388美元。对于Accolade Inc，目标价从6美元降至5美元，维持“与大市同步”评级。对于Cardinal Health Inc，目标价从127美元升至136美元，维持“跑赢大市”评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/OTE1MjMxNjI4NTkwNjg5MDI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTE1MjMxNjI4NTkwNjg5MDI0.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"283371","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUM","LFST","GDRX","HCSG","MA","AMWL","DGX","ACCD","CAH","HCA","ELV","VEEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482221364","title":"卡地纳健康2024财年第三财季实现净利润4.16亿美元，同比增加8220.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482221364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482221364?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:01","pubTimestamp":1731168107,"startTime":"0","endTime":"0","summary":"11月10日，卡地纳健康公布财报，公告显示公司2024财年第三财季净利润为4.16亿美元，同比增加8220.00%；其中营业收入为522.77亿美元，同比减少4.54%，每股基本收益为1.71美元。从资产负债表来看，卡地纳健康总负债463.35亿美元，其中短期债务9.40亿美元，资产负债比为0.93，流动比率为0.95。机构评级：截至2024年11月10日，当前有15家机构对卡地纳健康目标价做出预测，其中目标均价为126.40美元，其中最低目标价为101.00美元，最高目标价为145.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000207a22785ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000207a22785ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146173123","title":"异动解读 | 特药销售强劲 卡地纳健康上调年度利润预期引发股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1146173123","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146173123?lang=zh_cn&edition=full","pubTime":"2024-11-02 06:14","pubTimestamp":1730499286,"startTime":"0","endTime":"0","summary":"11月1日,全美领先的药品分销商卡地纳健康公司盘中股价大涨9.53%,报114.42美元,引发了市场的广泛关注。这一利好预期主要源于公司制药业务的强劲表现。与此同时,该公司此前以11.2亿美元收购了社区癌症中心运营商Integrated Oncology Network,进一步加大了在特药和复杂疾病治疗药物领域的布局。分析人士认为,这一举措将增强公司在高利润细分市场的竞争力,提升其长期增长潜力,从而支撑当日股价的大涨行情。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardinalhealth.com","stockEarnings":[{"period":"1week","weight":0.0913},{"period":"1month","weight":0.158},{"period":"3month","weight":-0.0128},{"period":"6month","weight":0.0724},{"period":"1year","weight":0.3844},{"period":"ytd","weight":0.0349}],"compareEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.0898},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.2291},{"period":"ytd","weight":0.0808}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"卡地纳健康集团是一家成立于1979年的俄亥俄州公司，是一家全球整合的医疗服务和产品公司，为医院，医疗系统，药房，门诊手术中心，临床实验室，医师办公室和家庭患者提供定制化解决方案。该公司提供药品和医疗产品以及具有成本效益的解决方案，以提高供应链效率。该公司将患者，提供者，付款人，药剂师和制造商联系在一起，以实现综合护理协调和更好的患者管理。该公司管理其业务并报告其财务业绩，分为两个部分：制药和医疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.72093,"avgChangeRate":0.0383},{"month":2,"riseRate":0.697674,"avgChangeRate":0.015847},{"month":3,"riseRate":0.534884,"avgChangeRate":0.010705},{"month":4,"riseRate":0.395349,"avgChangeRate":-0.006028},{"month":5,"riseRate":0.627907,"avgChangeRate":0.020617},{"month":6,"riseRate":0.55814,"avgChangeRate":0.018088},{"month":7,"riseRate":0.595238,"avgChangeRate":0.00635},{"month":8,"riseRate":0.512195,"avgChangeRate":0.002245},{"month":9,"riseRate":0.511628,"avgChangeRate":0.009806},{"month":10,"riseRate":0.488372,"avgChangeRate":-0.017903},{"month":11,"riseRate":0.697674,"avgChangeRate":0.03615},{"month":12,"riseRate":0.534884,"avgChangeRate":0.009388}],"exchange":"NYSE","name":"卡地纳健康","nameEN":"Cardinal Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卡地纳健康(CAH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卡地纳健康,CAH,卡地纳健康股票,卡地纳健康股票老虎,卡地纳健康股票老虎国际,卡地纳健康行情,卡地纳健康股票行情,卡地纳健康股价,卡地纳健康股市,卡地纳健康股票价格,卡地纳健康股票交易,卡地纳健康股票购买,卡地纳健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卡地纳健康(CAH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}